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Purpose: Occlusive disease of the aortoiliac segment may lead to limb-threatening ischemia, 
if coexisting disease is present in the femoral, popliteal, or tibial arteries. The combined 
treatment of severe aortoiliac and infrainguinal disease with standard techniques may be 
hazardous or contraindicated in patients with multiple previous reconstructions, severe 
comorbid medical illnesses, or both. This report summarizes the technical feasibility and 
early results of aortoiliac endovascular stented grafts (ESGs) in combination with conven- 
tional surgical reconstructions for the treatment of multilevel arterial occlusive disease. 
Methods: Seventeen patients with multilevel aortoiliofemoral limb-threatening occlusive 
disease had an ESG inserted to treat long-segment occlusive disease followed by a conven- 
tional surgical bypass. ESGs originated from the aortoiliac junction (seven) or the common 
iliac artery (10) and were inserted into the common femoral (nine), superficial femoral 
(four), or deep femoral (four) artery. ESG lengths ranged from 16 to 30 cm (mean, 21 cm). 
Conventional surgical bypasses were constructed from polytetrafluoroethylene (15) or 
saphenous vein (two) and extended to the popliteal (12), tibial (two), or contralateral 
femoral (three) arteries. 
Results: Technical success in graft insertion was achieved in 17 (94%) of 18 attempted ESG 
procedures. The 1-year primary and secondary cumulative patency rates for ESGs were 
94% + 10% and 100%, respectively, whereas the 1- and 2-year patency rates for the 
extravascular g afts were 92%-+ 10% and 100%, respectively. Four patients had minor 
postprocedure complications (23%), and no deaths occurred. One patient lost his limb at 
16 months because of severe pedal sepsis. 
Conclusions: Transluminally placed stented grafts in combination with conventional surgi- 
cal infrainguinal bypasses are a technically feasible and potentially safe option for the 
treatment of limb-threatening aortoiliofemoral occlusive disease and have demonstrated 
encouraging early patency. Long-term follow-up will be necessary before widespread 
application of this technique is advocated. (J VAse SuRa 1995;22:316-25.) 
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Patients who have limb-threatening ischemia 
caused by atherosclerosis generally have diffuse 
multilevel disease that often requires treatment above 
and below the inguinal ligament or at several evels 
distal to the iliac arteries. These patients are fre- 
quently older and more likely to have hypertension, 
diabetes, and other manifestations of symptomatic 
atherosclerotic disease when compared with patients 
with single-level occlusive disease. >5 In addition, 
approximately 12% to 15% of these patients require 
suprainguinal nd infrainguinal procedures to appro- 
priately treat their severe ischemic hanges. 6 
Prosthetic arterial bypasses have been the stan- 
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dard treatment for lower extremity ischemia caused 
by extensive aortoiliac occlusive disease. 6-9 Unfor- 
tunately, significant morbidity and mortality may be 
associated with these procedures, especially in those 
patients vdth serious comorbid medical illnesses. In 
addition, between 10% and 20% of aortofemoral 
grafts may be expected to develop graft limb throm- 
bosis during a 10-year period, necessitating a sec- 
ondary aortoiliac reconstruction with additional 
morbidity. 9ql 
Satisfactory results of an alternative intervention 
with percutaneous balloon angioplasty have been 
demonstrated for short (< 5 cm) iliac lesions, pre- 
dominantly in the common iliac arteries. 12'13 More 
complex lesions that demonstrate r sistance to bal- 
loon dilation have also been effectively treated by the 
insertion of intravascular stents. ~4q7 These proce- 
dures are associated with limited morbidity and 
virtually no death and may be offered to medically ill 
patients who would be at increased risk for surgical 
reconstruction. 
However, in spite of the encouraging results for 
isolated short stenoses, long-segment disease involv- 
ing the external iliac arteries does not appear to be 
effectively treated by dilatation alone. Is Angioplasty 
of such extensive arterial occlusive disease frequently 
results in vessels with diffuse intimal fracturing and 
dissections that are at high risk of thrombosis. 
A new technology combines intravascular stents 
and prosthetic grafts to form stented grafts that are 
capable of excluding extensive and complex vascular 
lesions. 19'2° One of the first clinical applications of 
this concept to treat extensive occlusive arterial 
disease was by Volodos et al. 2~ in 1986. With a series 
of self-expanding metallic stents covered by a poly- 
ester graft, this group reconstructed a long-segment 
left iliac artery stenosis by a retrograde f moral artery 
approach. 
This report describes the first series of transfemo- 
ral endovascular ortoiliac stented graft reconstruc- 
tions performed in combination with conventional 
surgical arterial bypasses to treat a patient population 
with multilevel aortoiliofemoral occlusive disease 
undergoing limb salvage. 
MATERIAL AND METHODS 
Patients. During a 24-month period, 17 patients 
with limb-threatening ischemia caused by aortoiliac 
and femoropopliteal occlusive disease were treated 
with endovascular stented grafts (ESGs) and stan- 
dard infrainguinal reconstructions. Eleven men and 
six women whose ages ranged from 43 to 82 years 
(mean, 64 years) were studied. Two patients had 
Table I. Coexisting medical problems in 
patients undergoing endovascular stent graft 
procedures and extravascular reconstructions 
Comorbidi~, No. of patients 
Acute myocardial infarction 1 
Severe coronary, artery disease; congestive 14 
heart failure 
Chronic obstructive pulmonary disease 5 
Diabetes 8 
Renal failure 3 
Hypertension 13 
Stroke 4 
Hostile abdomen/scarred groin ~ 8 
>_2 Previous aortic or groin explorations with and without 
infection. 
severe ischemic rest pain, whereas the remaining 15 
patients had varying degrees of ischemic tissue 
necrosis. All patients had one or more coexisting 
medical problems or greater than two failed previous 
aortofemoral reconstructions (Table I). Pulse volume 
recordings, anlde/brachial indexes, and aortography 
with femoropopliteal nd tibial runoff views were 
performed in all patients before and after each 
intervention. 
Operative technique. All procedures were per- 
formed with an open dissection and exposure of the 
anticipated arterial access ite. Based on the overall 
condition of the patient at the time of the procedure, 
either general (five), epidural (11), or local (one) 
anesthesia was selected. Two techniques for arterial 
recanalization were used to create a wide tract within 
the diseased iliac arteries. When the contralateral iliac 
artery was patent, recanalization was carried out by 
means of a contralateral, percutaneously inserted 
guidewire, "up and over" the aortic bifurcation, 
developing a prograde arterial wall dissection plane 
(Fig. 1). This technique allows for maximal control of 
arterial inflow and ensures that the recanalization 
process begins within the native arterial lumen. When 
the "up and over" approach was not technically 
feasible, retrograde recanalization was used (Fig. 2). 
Recanalizations were performed through an oc- 
cluded artery in six patients and through a diffusely 
stenotic but patent vessel in 11 patients. Each arterial 
recanalization was accomplished with a 0.035-inch 
hydrOphilic guidewire and an angled directional 
catheter (Meditech Corp.,Watertown, Mass.). Sev- 
enteen of 18 patients underwent successful recanali- 
zation with one of the previously mentioned tech- 
niques. The only patient who did not undergo 
successful recanalization underwent an axillofemoral 
bypass. 
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Fig. 1. Surgical procedure of ndovascular grafting: "Up and over" technique. For details, see 
text. 
After successful wire recanalization was per- 
formed, each iliac artery was dilated along the length 
of disease with an 8 mm diameter angioplasty 
balloon (Meditech Corp.). Each stented graft was 
composed of a Palmaz balloon expandable stent 
(lohnson & lohnson Interventional Systems, War- 
ren, N. J. [stent-P-294]) that was sutured with four 
CV-6 polytetrafluoroethylene (PTFE) sutures 
(W.L. Gore and Associates, Flagstaff, Ariz.) to the 
proximal end of a 6 mm thin-walled PTFE graft 
(W.L. Gore and Associates). The proximal 15 mm 
of the graft that overlapped the stent was devoid 
of its outer wrap. Each stented graft was then 
coaxially mounted on an 8 mm x 4 cm balloon 
angiopIasty catheter (Blue Max, Meditech Corp.) 
and was placed within a single 14F hemostatic 
introducing sheath with a tapered balloon tip made 
from an Ultrathin angioplasty balloon (Meditech 
Corp.). Once the device was fluoroscopically located 
in a predetermined site, the sheath was partially 
retracted, permitting proximal stent deployment. 
The introducer sheath was then completely with- 
drawn, allowing a redundant portion of the distal 
end of the graft to emerge from the access vessel. 
The distal ESG "was then endoluminally or 
extraluminally anastomosed with one of the tech- 
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niques illustrated in Fig. 3. These include an endolu- 
minal anastomosis to .,ttie femoral artery that is 
separate (type 1 [!~ig. 3, 1]) or included (type 2 
[Fig. 3, 2]) as part of the proximal anastomosis ofthe 
extraluming)~?aft ex ension; an end-to-side anasto- 
mosis (type 3 [Fig. 3, 3]) to the superficial femoral 
artery with an extension to the patent distal arterial 
tree; an end-to-side anastomosis (type 4 [Fig. 3, 4]) 
or a side-to-side anastomosis (type 5 [Fig. 3, 5]) to 
the patent profunda femoris artery with a distal 
extension; or a direct continuation tothe popliteal or 
infrapopliteal outflow vessel (type 6 [Fig. 3, 6]) 
bypassing two sequential levels of arterial occlusive 
disease. 
An intraoperative completion angiogram was 
performed at the conclusion of each endovascular 
graft procedure. In four (23%) instances mild graft 
stenoses from inadequate graft expansion or extralu- 
minal compression were detected. All of these lesions 
were effectively corrected by alloon dilatation of the 
graft segment (three) or the insertion of a free 
intragraft stent (one). 
ESGs originated from the aortoiliac junction 
(seven) or the common iliac artery (10) and were 
inserted into the common femoral (nine), superficial 
femoral (four), or deep femoral (four) artery with 
endovascular nastomoses. ESG lengths ranged from 
16 to 30 cm (mean, 21 cm). Conventional surgical 
infrainguinal bypasses were performed immediately 
after the endovascular ortoiliofemoral reconstruc- 
tions were successfully completed. Twelve patients 
received femoropopliteal bypasses with PTFE (eight 
above-lmee, four below-knee), three had femoro- 
femoral bypasses with PTFE, and two had femo- 
rotibial reconstructions with reversed greater saphe- 
nous veins. 
Follow-up studies. All patients underwent pre- 
operative and postoperative pulse volume recordings 
and a determination of the anlde/brachial index. 
Postoperative follow-up pulse volume recordings, 
ankle/brachial indexes, and duplex evaluations were 
performecl at regular intervals (3 months, 6 months, 
and every 6 months thereafter). In every case a 
postoperative follow-up arteriogram was performed 
at 3 days, and additional arteriograms were obtained 
at any interval where a problem was detected by 
physical examination or by a noninvasive study. 
Anticoagulation. Systemic heparin was admin- 
istered uring each ESG insertion procedure. Long- 
term anticoagulation was not used. 
RESULTS 
Technical success in arterial recanalization was 
achieved in 17 (94%) of the 18 cases. Eleven were 
totally occluded arterial segments, whereas ix were 
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Fig. 2. Surgical procedure ofendovascular grafting: Ret- 
rograde technique-For details, see text. 
diffusely stenotic. After endovascular ortoiliofemo- 
ral reconstruction a d conventiOnal surgical bypass 
were performed, ankle/brachial indexes ignificantly 
improved (p < 0.0S) from a mean of 0.39 to 0.76, 
and the thigh pulse volume recordings improved 
from a mean of 9.75 to a mean of 37.8. The i-year 
primary and secondary cumulative life table patency 
rates for all ESGs were 94% _+ 10% and 100%, 
respectively (Fig. 4). Three grafts required a throm- 
bectomy during a 24-month follow-up period. One 
graft failed because of progression of distal disease, 
one because of proximal embolic disease, and one 
because of a proximal common iliac stenosis. All were 
successfully revised, but one patient still required an 
amputation because of severe, acute, pedal sepsis. 
The 1-year primary and secondary cumulative life 
table patency rates for all standard extravascular 
bypasses were 92% -+ i0% and 100%, respectively 
(Fig. 4). Three extraluminal grafts required revisions: 
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Fig. 3. Distal end of endovascular graft can be anastomosed to patent distal arterial tree in 
several ways. (1) Type 1, endoluminal nastomosis to femoral artery is performed and separate 
proximal anastomosis of distal extravascular graft is performed to femoral arteriotomy. (2) Type 
2, intravascular anastomosis and proximal anastomosis f distal extravascular graft are included 
in single anastomotic closure. (3) Type 3, stented graft is brought out through femoral 
arteriotomy and anastomosed to patent distal superficial femoral artery. From this site distal 
extension or crossover femorofemoral extension can be performed if necessa U. (4) Type 4, 
endovascular g aft is brought out through femoral arteriotomy and anastomosed to patent distal 
deep femoral artery. Extension to distal arterial tree or to contralateral femoral arte U can be 
performed from this graft if necessary. (5) Type 5, end of endovascular graft is brought our 
through femoral arteriotomy and distal graft extension is anastomosed nd-to-end to this graft, 
side-to-side to patent distal deep femoral artery and extended further to distal arterial tree. (6) 
Type 6, endovascular g aft is brought out through femoral arteriotomy and can bypass multiple 
levels of occlusive disease nd be anasromosed distally to popliteal or tibial arteries if all femoral 
vessels are occluded. EG represents endovascular graft; BG represents distal bypass graft; SFA 
represents superficial femoral artery; DFA represents deep femoral artery; CFA represents 
common femoral artery. 
one graft failed while the associated ESG maintained 
normal function, and the other two presented in the 
failing state with outflow vessel lesions. All three 
grafts were revised; two required distal extensions 
and one a thrombectomy. 
No deaths were associated with this series. Minor 
complications occurred in four (23%) instances: one 
subendocardial myocardial infarction, one lympho- 
cele, and two groin hematomas. 
D ISCUSSION 
In spite of the great successes associated with 
aortoiliac reconstruction, pcrioperative morbidity 
and mortality and late graft limb failures may 
compromise the long-term results of these proce- 
dures, s,6 In addition, those patients with severe 
comorbid medical illnesses including cardiac, pulmo- 
nary, and renal insufficiency may not be suitable 
candidates for extensive aortoiliac reconstruction. 
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Fig. 4. Twelve-month life-table cumulative primary patency rates for endovascular and 
extravascular grafts were 94% and 92%, respectively. Number of grafts at each interval are 
indicated by numbers in table. 
Moreover, patients who have severe lower extremity 
ischemia requiring amultilevel arterial reconstruction 
for diffuse atherosclerotic disease are at an even 
higher risk of perioperative complications. 
Other less invasive surgical alternatives such as 
femorofemoral nd axillofemoral bypasses have been 
used to treat such patients with severe aortoiliac dis- 
ease and significant comorbid medical problems. 22-24 
However, these bypasses are not as durable as direct 
aortic reconstructions, which have patency rates ex- 
ceeding 80% at 5 years 9'1°'25'26 compared with 5-year 
patency rates of 45% to 65% for femorofemoral nd 
axillofemoral procedures. 27-3s In addition, these ex- 
traanatomic bypasses require a surgical intervention 
on the inflow artery of an asymptomatic l mb. 
Alternatives to surgical repair of the aortoiliac 
segment include endovascular therapies such as 
percutaneous transluminal ngioplasty and, in suit- 
able candidates, intravascular stenting. 14'15'363s Al- 
though there have been encouraging results with 
these minimally invasive techniques in the manage- 
ment of localized arterial occlusive disease, the 
treatment of long-segment, complex, occlusive le- 
sions of the aortoiliac segment has not been as 
promising. 18 
The use of endovascular stented graft technology 
for the treatment of aortoiliac occlusive disease 
represents a blending of technologies that include 
prosthetic grafts, balloon angioplasty catheters, and 
intravascular stents (Fig. 5). ESGs were conceptual- 
ized by Dotrer 39 in 1969. Initial clinical reports of 
endovascular stented grafts for the treatment of 
arterial occlusive disease at the femoropopliteal nd 
aortoiliac levels have recently been published. 4°'41 In 
addition, the use of similar technology for the 
treatment ofaneurysmal disease and arterial trauma is 
also rapidly evolving. 19,42-44 This study reports the 
first series of patients with limb-threatening ischemia 
caused by multilevel arterial occlusive disease treated 
with this new and advancing technology in combi- 
nation with standard bypass procedures. 
Endovascular stcnted grafts have several theoretic 
advantages. Direct aortic inflow can be obtained, 
obviating the need to dissect and use an uninvolved 
artery for inflow (i.e., the contralateral femoral or 
axillary arteries) and potentially avoiding additional 
complications and arterial compromise to another 
extremity. These grafts can be inserted through 
remote access sites, thereby obviating the need to 
directly approach a diseased artery. The use of a 
remote arterial entrance site permits surgical treat- 
mcnt through small incisions without the need to 
displace and retract abdominal viscera or to perform 
an extensive retroperitoneal dissection to revascular- 
ize an occluded aorta or iliac artery. This minimally 
invasive approach allows a wide range of anesthetic 
choices for ESG procedures. Moreover, revascular- 
izations can be carried out through previously 
unusable, totally occluded arteries. In this series 35% 
of the arteries that were used as access sites for the 
rccanalization of aortoiliac segments were totally 
occluded at the time of the procedure. Such occluded 
arteries erve as entry points into the subintimal plane 
of the occluded vessel, permitting recanalization 
wires to dissect within the wall of the occluded artery 
and into the true lumen of the patent arterial 
segment. For these occluded segments retrograde 
entry into the true lumen of the patent proximal 
vessel after recanalization can be difficult and time- 
consuming. Recanalization of the occluded segment 
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Fig. 5. Sixty-two-year-old woman was admitted with limb-threatening ischemia of left lower 
extremity. A, Pelvic arteriogram shows diffuse iliac disease on both sides with left external iliac 
artery occlusion. B, Iliac artery occlusion was corrected by use ofendovascular stented graft from 
proximal common iliac artery to femoral artery, which was extended to popliteal artery. 
in a pr0grade fashion with the "up and over" 
technique after contralateral arterial puncture and 
advancement of the appropriate guidewire and cath- 
eter over the aortic bifurcation can lead to easier 
recanalization from the known patent proximal artery 
to the surgically exposed outflow vessel. Some 
additional advantages of this technique are the 
decreased chance of creating unwanted dissection 
planes in an arterial segment that will not be relined 
with a graft and the readily available proximal access 
for placement of an occluding balloon in case arterial 
rupture occurs during dilatation of the occluded 
segment. 
Endovascular grafting has been feasible when 
long, occluded segments are present. When other 
minimally invasive treatments such as long-segment 
angioplasty with or without stcnts are used for long 
occlusions, results have been poor, presumably be- 
cause highly thrombogenic flow surfaces with exten- 
sive intimal damage have been produced. Endovas- 
cular stented grafts provide a single, relatively non- 
thrombogenic flow surface to completely reline the 
dilated and frequently diffusely fi'actured and dis- 
sected arterial segments. Because prosthetic vascular 
grafts in the aortoiliac segment have traditionally had 
excellent long-term patency rates, 7"8 it might be 
anticipated that comparable patency rates will be 
achieved when similar prosthetic grafts are used in the 
endoluminal position. Other endovascular conduit 
choices including autogenous aphenous vein are 
possible. 
Several potential disadvantages of endovascular 
stented grafts exist. The biologic behavior of a 
prosthetic endovascular graft placed in a diffusely 
dilated atherosclerotic artery is unknown. Concern 
exists regarding the potential for arterial recoil after 
dilatation, disease progression, and smooth-muscle 
cell proliferation within atheromatous material ex- 
trinsic to the endovascular graft. These processes 
could result in extrinsic compression of the stented 
graft with subsequent failure. In our series some 
detectable extrinsic compression of endovascular 
stented grafts was noted immediately after four 
(23%) of the 17 aortoiliofemoral grafts were in- 
serted. These compression sites were detected by 
angiography and did not demonstrate hemodynamic 
significance. All compressive stented graft lesions 
were eliminated by either intragraft balloon dilata- 
tion (three) or placement of an additional intravas- 
cular stent (one). Follow-up studies in these four 
patients have not demonstrated recurrence of the 
compressive l sion. 
Three of our 17 ESGs required reintervention for 
a hemodynamically significant failing (two) or 
thrombosed (one) graft during the 24-month 
follow-up period of this study. Only one of these 
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demonstrated vidence of a hyperplastic lesion asso- 
ciated with the stented graft. In this instance hyper- 
plasia adjacent to the balloon-expandable st nt was 
responsible for the failing graft. Balloon dilatation of 
the stent resulted in restoration ofnormal flow within 
the endovascular g aft and persistent patency. The 
remaining two grafts that were detected inthe failing 
state had lesions within outflow arteries that were not 
directly associated with the ESGs. 
Technical problems may occur during the process 
of insertion of an endovascular stented graft for 
occlusive disease. These devices require long-segment 
balloon angioplasty of the native vessel before 
insertion. Such procedures could result in arterial 
rupture with resulting hemorrhage. Local wire per- 
foration ,during arterial recanalization was not un- 
common. However, artcrial rupture during balloon 
dilatation occurred in one instance. The perforation 
was managed by proximal balloon occlusion, a 
technique that was easily accomplished when the "up 
and over" recanalization procedure previously de- 
scribed was used. 
Additional technical imitations relate to the 
process of arterial recanalization. Because this proce- 
dure is performed under fluoroscopic ontrol, an 
image of the guidewire used for recanalization could 
be obtained in only two dimensions. This problem 
has led to difficulty in directing angiographic wires 
from a patent vessel, through the occluded arterial 
segment, and back into the patent proximal vessel 
during retrograde recanalization. The level of diffi- 
culty of this portion of the procedure varies from case 
to case but may be dependent on the chronicity of the 
arterial occlusion. The "up and over" technique, 
when feasible, has facilitated guidewire passage 
through the occluded segment. Technical success was 
achieved in 94% of the recanalization procedures 
attempted in this study, and it is expected that with 
improved three-dimensional imaging technology (in- 
travascular ultrasonography) and improvements in 
guidewire and catheter instrumentation, the limits of 
the procedure may be expanded. 
Finally, the need to perform an open arteriotomy 
for each endovascular stented graft procedure is 
usually adirect result of the overall size and bulkiness 
of the endovascular stented graft device and carrier 
system. The ESGs used in this study used standard 
thin-walled PTFE grafts. These standard grafts were 
designed for extraluminal use and probably have 
greater burst strength characteristics than will be 
needed for endovascular g afts. It is anticipated that 
with a better understanding of graft and stent 
attachment device requirements, a smaller profile 
device may be developed that would be suitable for 
percutaneous insertion in selected situations. How- 
ever, open arteriotomies will always represent an 
excellent alternative for gaining access in those cases 
in which a total arterial occlusion exists and intro- 
duction of the device must be made through this 
occluded segment. 
We have carried out reconstructive surgical proce- 
dures in the aortoiliac arterial segment for combined 
aortoiliac and femoropopliteal occlusive disease by 
using endovascular techniques in combination with 
conventional surgical bypasses. In our hands this pro- 
cedure has proved to be safe and effective with good 
short-term graft patency rates. In the future we shall 
increase our experience with this method and analyze 
the results of a larger number of patients for a longer 
period of time. Until firm conclusions regarding the 
performance of this method can be determined, its 
use must bc considered experimental. 
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D ISCUSSION 
Dr. Jock R. Wheeler (Norfolk, Va.). Assuming all 
these procedures were done in the operating room, what 
was the amount of radiation exposure to the patients 
during the length of the procedure? Also, was this 
procedure done under IRB control? In spite of the fact that 
all these devices have been approved, this is certainly an 
experimental procedure. It was also interesting that 6 mm 
grafts were used as inflow conduits. In an above-knee 
femoropopliteal study that we recently presented at a 
symposium in New York, we showed that 8 mm grafts had 
a higher patency rate than 6 mm grafts. Taking into account 
the technical limitations, is a 6 mm graft sufficient? Finally, 
because the patency rates and costs for this procedure must 
stand up to those of the "gold standard" of bypass, have you 
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looked at the total cost of these procedures, including the 
added cost of a secondary procedure, which was necessary 
in 23% of these cases? 
Dr. Lifts A. Sanchez. The procedures were performed 
under an IRB protocol at our institution. All the compo- 
nents you mentioned are FDA-approved for vascular 
surgery use, although they are not approved for this 
particular use. 
All procedures were performed in the operating room. 
In regard to the exposure to radiation, the average 
fluoroscopy time is around 20 minutes. If the recanaliza- 
tion procedure is difficult, such as in the initial cases we 
performed, then, of course, this time would be longer. 
However, I do not believe that this is very different from 
the exposure physicians receive in the radiology suite or 
from any other fluoroscopic procedure. 
The issue of cost is very important and will become 
even more important as we evaluate new procedures. We 
are beginning to analyze our data to determine whether, 
indeed, the cost is reduced and what effect, if any, there is 
on hospital resource use. Most patients admitted with 
significant ischemia, gangrene, or ulceration are in the 
hospital for long periods of time after they undergo 
revascularization because of wound care and long-term 
placement problems, not because of the initial intervention. 
I am not sure if there will be any cost savings with these 
patients. It is hoped that there will be some improvement 
in the use of hospital resources as well as morbidity and 
mortality rates. We do, however, expect a significant 
improvement in length of stay and cost in patients with 
aneurysmal nd traumatic arterial disease. 
The reinterventions ecessary in most of these patients 
were for progression of their arterial disease during the 
initial 12 to 14 months of follow-up. As with any other 
bypass, they required a percutaneous intervention or an 
extension of their reconstruction. 
Dr. J. Harold Harr ison (Atlanta, Ga.). I am sure I 
must have missed something. Ordinarily, restoring flow to 
the deep femoral artery is all that is necessary inthe presence 
of a combination of diseases involving the iliac and femoral 
arteries. Did I understand correctly that you are routinely 
restoring flow through the iliac artery or the aorta above 
and then performing a femoropopliteal bypass at the same 
time? 
Dr. Sanchez. Patients with lower extremity ischemia 
without foot lesions usually only need the first level of 
occlusive disease corrected, so that a bypass to the deep 
femoral artery is usually sufficient. However, all the patients 
in our group had significant areas of gangrene or ulceration 
that required straight-line flow to the foot for healing. 
Dr. Harrison. How did you know ahead of time? We 
do not have to do that very often. The deep femoral artery 
is the best thing in the world. 
Dr. Sanchez. We did not know ahead of time. 
However, these patients had significant ischemia nd we 
did not want to put them through two separate recon- 
structions. Our decision on whether to perform a sequen- 
tial reconstruction was based on the presence of poor 
collateral vessels, a diseased or small deep femoral artery, 
extremely poor pulse volume recordings, and the size of the 
lesion that needed to heal. 
Dr. Stanley O. Snyder (Norfolk, Va.). In looking at 
your drawings, it appears that you are bypassing to the deep 
femoral artery but then ligating it proximally so that you 
condemn yourself to profunda occlusion if your iliac-to- 
deep femoral artery bypass fails. That is a little different 
than what occurs with a routine iliac-to-femoral rtery 
bypass. Also, it seems that you are condemning all the 
collateral vessels that come into the common femoral and 
the internal iliac artery. 
I hope that one of these days someone will report on 
what happens to the surgeons during these 20 minutes of 
fluoroscopy time. I hope the patient is exposed only once 
or twice. 
Dr. Sanchez. We are carefully following the radiation 
protocols at our institution. We believe that, to prevent any 
possible long-term injuries, it is very important that all the 
devices, as well as the protective equipment we use, are the 
best available. 
All patients had an occluded internal i iac artery, which, 
as you suggested, is a very important collateral to the lower 
extremity. In addition, most branches of the external i iac 
artery were also occluded. The grafts to the deep femoral 
artery were anastomosed end-to-side to maintain the 
patency of the collateral vessels and their branches. 
Dr. Snyder. I hope that, if your grafts do occlude later 
during follow-up, you will report he amputation levels if 
they become a factor. 
Dr. Sanehez. Absolutely, because that is a very 
important consideration. 
Dr. Alan Lumsden (Atlanta, Ga.). The procedure is a 
frightening one because it is so easy to perform, you 
predilate the graft and the graft protrudes from the femoral 
anastomosis. In those patients in whom you then perform 
infrainguinal bypass procedures, are you sewing to the 
predilated portion of the PTFE? 
Dr. Sanchez. The area of the graft used for the 
anastomosis to another graft or the native artery is not 
predilated. The final reconstruction depends entirely on the 
patient's anatomy. 
